Open Access
Endosc Int Open 2016; 04(03): E296-E300
DOI: 10.1055/s-0042-101940
Case report
© Georg Thieme Verlag KG Stuttgart · New York

Biodegradable stents for the treatment of bowel strictures in Crohn's disease: technical results and challenges

John Gásdal Karstensen
1   Gastro Unit, Division of Endoscopy, Copenhagen University Hospital Herlev, Denmark
2   Gastro Unit, Division of Surgery, Copenhagen University Hospital Hvidovre, Denmark
,
Katrine Risager Christensen
1   Gastro Unit, Division of Endoscopy, Copenhagen University Hospital Herlev, Denmark
,
Jørn Brynskov
1   Gastro Unit, Division of Endoscopy, Copenhagen University Hospital Herlev, Denmark
,
Claus Rønholt
3   Gastro Unit, Division of Surgery, Copenhagen University Hospital Herlev, Denmark
,
Peter Vilmann
1   Gastro Unit, Division of Endoscopy, Copenhagen University Hospital Herlev, Denmark
,
Jakob Hendel
1   Gastro Unit, Division of Endoscopy, Copenhagen University Hospital Herlev, Denmark
› Author Affiliations
Further Information

Publication History

submitted 05 November 2015

accepted after revision 19 January 2016

Publication Date:
18 March 2016 (online)

Preview

Background and study aims: In patients with Crohn’s disease, the idea of biodegradable stents for treatment of bowel strictures with limited effect of endoscopic balloon dilation is tempting and initial results have been promising. The aim of this study was to evaluate the technical and clinical success of biodegradable stents for treatment of inflamed Crohn’s strictures refractory to endoscopic balloon dilatation.

Patients and methods: Consecutive patients treated with biodegradable stents due to Crohn’s disease and inflamed bowel strictures refractory to endoscopic balloon dilatation were included. Technical and clinical success were evaluated.

Results: Six patients were included in the study. Technical success was obtained in five patients (83 %). Clinical success was limited to one patient (20 %); failure was observed due to mucosal overgrowth (n = 2), stent migration (n = 1), and stent collapse (n = 1).

Conclusions: In Crohn’s disease, it is technically feasible to treat bowel strictures with biodegradable stents. However, we have stopped using biodegradable stents due to lack of clinical success and side effects such as mucosal overgrowth and stent collapse.